Get Our Free Research Email
April 27-27 - American Board of Cosmetic Dentistry
May 4-April 7 - American Society of Gene & Cell Therapy Annual Meeting 2016Complete Calendar »
Apr 26 @ 4:30 PM ET - NuVasive
Apr 28 @ 8:00 AM ET - Zimmer BiometComplete Calendar »
Dental News Roundup June 2014 BY MATTHEW JAFFE, JUNE 26, 2014
Nobel Biocare reported financial results for 1Q:14. Revenue was €138.8 million ($192.2 million), missing consensus estimates by 2%, and representing increase of 3% from €141.5 million ($181.35 million) in 1Q:13. Gross margin declined slightly to 75.1% in 1Q:14 from 76.6% in 1Q:13. The company's Europe, Middle East and Africa (EMEA), Americas and Asia/Pacific regions grew at 2%, 3%, and 6% respectively in 1Q:14. All growth rates are on a constant currency basis.
Patterson Companies reported financial results for 4Q:14. Net sales were $1,102.1 million in 4Q:14, missing consensus estimates by 2%, and representing an increase of 14% compared to $964.9 million in 4Q:13. Gross margin declined to 28.7% in 4Q:14 from 33.6% in 4Q:13. Dental sales, which are about 60% of Company sales, decreased 1.5%, compared to the fourth quarter last year to $622.8 million in the fourth quarter this year. The company's results by category for Consumable Dental Supplies, Dental Equipment and Software and Other Dental Services and Products were 0.4%, (4.7%) and 0% respectively. All growth rates are on a constant currency basis.
Sirona reported financial results for its 2Q:14. Revenue was $282.7 million, beating consensus estimates by 3% and increasing 3% from $267.3 million in 2Q:13. Gross margin decreased in 2Q:14 to 53.6% from 54.1% in 2Q:13. The company's segments grew at: Instruments 9%, CAD/CAM 3%, Imaging Systems 3%, and Treatment Centers 1% in 2Q:14. Domestic revenue grew 4.5%, while international revenue grew 2.3% compared to the same quarter last year. All growth rates are on a constant currency basis.
Straumann reported financial results. Revenue in 1Q:14 was CHF 179.8 million ($202.7 million), beating consensus by 2% and representing an increase of 6% from CHF 174.8 million ($184.0 million) in 1Q:13. The company's Europe, North America, Asia/Pacific and Rest of the World regions grew at 4%, 5%, 8% and 29% respectively in 1Q:14. All growth rates are on a constant currency basis.
Henry Schein reported financial results for 1Q:14. Net sales were $2,430 million in 1Q:14, in line with consensus estimates and representing an increase of 6% compared to $2,294 million in 1Q:13. Gross margin slightly increased to 28.7% in 1Q:14 from 28.2% in 1Q:13. The company's segments grew at: Dental 4%, Animal Health 2%, Medical 2%, Technology and Value-added Service 6% in 1Q:14. All growth rates are on a constant currency basis and exclude affects of acquisitions.
Straumann and 3M announced a trusted connection with the Straumann Cares system for the 3M True Definition Scanner (TDF). This will allow dentist to restore a Straumann implant with Cares prosthetic from a single TDF intra-oral scan. In the new workflow, after the digital impression is captured, the dentist can now select a Straumann implant in the scanners prescription screen and send to a dental lab using the Cares system.
Patterson Companies announced the retirement of Executive Vice President & CFO R. Stephen Armstrong, who has been with the company for 15 years and will depart in October. Ann B. Gugino, who has been Patterson's vice president of strategy and planning since 2012, will succeed Mr. Armstrong as CFO effective November 1, 2014. Ms. Gugino also serves on the board of directors of Oral health America and Washburn Children's Center.